Prooxidative activities of 10 phenazine derivatives relative to that of clofazimine
Author(s) -
Birgit M. Zeis,
Ronald Anderson,
John O’Sullivan
Publication year - 1987
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.31.5.789
Subject(s) - clofazimine , phenazine , superoxide , chemistry , myeloperoxidase , antimycobacterial , plumbagin , luminol , reactive oxygen species , chemiluminescence , biochemistry , pharmacology , organic chemistry , biology , enzyme , medicine , immunology , inflammation , mycobacterium tuberculosis , tuberculosis , leprosy , pathology , genetics
The objective of this study was to investigate the relationship between the antimycobacterial properties of the antileprosy drug clofazimine and its stimulatory effect on the release of reactive oxidants by polymorphonuclear leukocytes by using a variety of phenazine derivatives. The effects of these compounds on myeloperoxidase-mediated iodination, luminol-enhanced chemiluminescence, and the release of superoxide anion by polymorphonuclear leukocytes were investigated. Dissociation of the antimycobacterial and prooxidative effects of clofazimine was possible by manipulation of the chemical group in position 2 of the phenazine molecule. When nitrogen-containing substituents in this position were replaced by oxygen, the mode of the prooxidative action of the compounds was altered.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom